Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Convertible Debt (2022)

Historic Convertible Debt for ADC Therapeutics (ADCT) over the last 1 years, with Q4 2021 value amounting to $113.8 million.

  • ADC Therapeutics' Convertible Debt changed N/A to $113.8 million in Q4 2021 from the same period last year, while for Dec 2021 it was $113.8 million, marking a year-over-year change of. This contributed to the annual value of $113.8 million for FY2021, which is N/A changed from last year.
  • As of Q4 2021, ADC Therapeutics' Convertible Debt stood at $113.8 million.
  • In the past 5 years, ADC Therapeutics' Convertible Debt ranged from a high of $113.8 million in Q4 2021 and a low of $113.8 million during Q4 2021